 Xenobiotics
"Xenobiotics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc.
| Descriptor ID |
D015262
|
| MeSH Number(s) |
D26.969
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Xenobiotics".
Below are MeSH descriptors whose meaning is more specific than "Xenobiotics".
This graph shows the total number of publications written about "Xenobiotics" by people in this website by year, and whether "Xenobiotics" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 1 | 1 | 2 | | 2006 | 0 | 1 | 1 | | 2011 | 1 | 1 | 2 | | 2012 | 3 | 0 | 3 | | 2013 | 0 | 1 | 1 | | 2015 | 2 | 0 | 2 | | 2016 | 0 | 2 | 2 | | 2019 | 1 | 0 | 1 | | 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Xenobiotics" by people in Profiles.
-
Russell JN, Perry BJ, Bergsveinson J, Freeman CN, Sheedy C, Nilsson D, Braul L, Yost CK. Metagenomic and metatranscriptomic analysis reveals enrichment for xenobiotic-degrading bacterial specialists and xenobiotic-degrading genes in a Canadian Prairie two-cell biobed system. Environ Microbiol Rep. 2021 10; 13(5):720-727.
-
Costenbader KH, DiIorio M, Chu SH, Cui J, Sparks JA, Lu B, Moss L, Kelmenson L, Feser M, Edison J, Clish C, Lasky-Su J, Deane KD, Karlson EW. Circulating blood metabolite trajectories and risk of rheumatoid arthritis among military personnel in the Department of Defense Biorepository. Ann Rheum Dis. 2021 08; 80(8):989-996.
-
Fohner AE, Dalton R, Skagen K, Jackson K, Claw KG, Hopkins SE, Robinson R, Khan BA, Prasad B, Schuetz EG, Nickerson DA, Thornton TA, Dillard DA, Boyer BB, Thummel KE, Woodahl EL. Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function. Clin Transl Sci. 2021 Jul; 14(4):1292-1302.
-
Li H, Lampe JN. Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism. Arch Biochem Biophys. 2019 09 30; 673:108078.
-
Niyonsaba E, Easton MW, Feng E, Yu Z, Zhang Z, Sheng H, Kong J, Easterling LF, Milton J, Chobanian HR, Deprez NR, Cancilla MT, Kilaz G, Kentt?maa HI. Differentiation of Deprotonated Acyl-, N-, and O-Glucuronide Drug Metabolites by Using Tandem Mass Spectrometry Based on Gas-Phase Ion-Molecule Reactions Followed by Collision-Activated Dissociation. Anal Chem. 2019 09 03; 91(17):11388-11396.
-
Speidel JT, Xu M, Abdel-Rahman SZ. Differential effect of ABCB1 haplotypes on promoter activity. Pharmacogenet Genomics. 2018 03; 28(3):69-77.
-
Ladage ML, King SD, Burks DJ, Quan DL, Garcia AM, Azad RK, Padilla PA. Glucose or Altered Ceramide Biosynthesis Mediate Oxygen Deprivation Sensitivity Through Novel Pathways Revealed by Transcriptome Analysis in Caenorhabditis elegans. G3 (Bethesda). 2016 10 13; 6(10):3149-3160.
-
Albrecht C, Caniggia I, Clifton V, G?hner C, Harris L, Hemmings D, Jawerbaum A, Johnstone E, Jones H, Keelan J, Lewis R, Mitchell M, Murthi P, Powell T, Saffery R, Smith R, Vaillancourt C, Wadsack C, Salomon C. IFPA meeting 2015 workshop report III: nanomedicine applications and exosome biology, xenobiotics and endocrine disruptors and pregnancy, and lipid. Placenta. 2016 12; 48 Suppl 1:S12-S16.
-
Quinn RA, Phelan VV, Whiteson KL, Garg N, Bailey BA, Lim YW, Conrad DJ, Dorrestein PC, Rohwer FL. Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome. ISME J. 2016 06; 10(6):1483-98.
-
Bachtell R, Hutchinson MR, Wang X, Rice KC, Maier SF, Watkins LR. Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4. CNS Neurol Disord Drug Targets. 2015; 14(6):692-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|